Health Reform, Medicaid Expansions, and Women's Cancer Screening

Ku, Leighton; Bysshe, Tyler; Steinmetz, Erika; Bruen, Brian

doi:10.1016/j.whi.2016.01.002

Cited by 12 publications

(5 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…10,36,37 In the absence of health insurance coverage, many forgo cancer screening and/or delay diagnosis and thus are likely to experience poor clinical outcomes, including higher cancer-specific mortality. 37,38 Patients who have health care plans that require significant cost-sharing because of high deductibles and/or high coinsurance face similar barriers in access to timely and comprehensive cancer care, given the insufficient financial protection from medical expenditures. 36,37,39 Thus, as the patient with cancer undergoes treatment, he or she faces an accumulation of direct medical and surgical costs.…”

Section: A Household Economic Perspective On Financial Toxicitymentioning

confidence: 99%

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Carrera

Kantarjian

Blinder

2018

CA A Cancer J Clinicians

602

591

View full text Add to dashboard Cite

"Financial toxicity" has now become a familiar term used in the discussion of cancer drugs, and it is gaining traction in the literature given the high price of newer classes of therapies. However, as a phenomenon in the contemporary treatment and care of people with cancer, financial toxicity is not fully understood, with the discussion on mitigation mainly geared toward interventions at the health system level. Although important, health policy prescriptions take time before their intended results manifest, if they are implemented at all. They require corresponding strategies at the individual patient level. In this review, the authors discuss the nature of financial toxicity, defined as the objective financial burden and subjective financial distress of patients with cancer, as a result of treatments using innovative drugs and concomitant health services. They discuss coping with financial toxicity by patients and how maladaptive coping leads to poor health and nonhealth outcomes. They cover management strategies for oncologists, including having the difficult and urgent conversation about the cost and value of cancer treatment, availability of and access to resources, and assessment of financial toxicity as part of supportive care in the provision of comprehensive cancer care. CA Cancer J Clin 2018;68:153-165.

show abstract

Section: A Household Economic Perspective On Financial Toxicitymentioning

confidence: 99%

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Carrera

Kantarjian

Blinder

2018

CA A Cancer J Clinicians

602

591

View full text Add to dashboard Cite

show abstract

“…Financial toxicity affects material (monetary) and psychological (stress) domains and results in maladaptive coping behaviors which subsequently may worsen the former and negatively influence clinical outcome, summarized in Figure . The impact of financial toxicity may even be felt before cancer diagnosis, as patients who are underinsured may have a delay to diagnosis and worse outcome due to lack of regular medical appointments and screening …”

Section: Consequences Of Financial Toxicitymentioning

confidence: 99%

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Lentz

Benson

Kircher

2019

Journal of Surgical Oncology

222

229

View full text Add to dashboard Cite

Financial toxicity is the adverse impact of a cancer diagnosis on a patient’s financial well‐being resulting from direct or indirect costs. Potential consequences of financial toxicity include material loss, psychological distress, and/or maladaptive coping strategies. This review will summarize the prevalence, causes, and consequences of financial toxicity, with an emphasis on strategies to anticipate and reduce its burden. Improvement will require multilevel, coordinated efforts between stakeholders including patients, providers, health systems, payers, manufacturers, and policymakers.

show abstract

“…Paperwork barriers are a leading reason why children in this range are uninsured or have gaps in coverage (Koetting, 2016). Our findings indicate that children living in states with 12-month continuous eligibility are less likely to have gaps in their insurance coverage, which has been associated with lower average monthly Medicaid costs and ongoing relationships with medical care providers (Ku et al, 2015). The analyses also show that continuous eligibility is associated with fewer gaps attributed to application problems, suggesting that the policy is effective in reducing paperwork barriers.…”

Section: Discussionmentioning

confidence: 87%

Continuous Eligibility for Medicaid Associated With Improved Child Health Outcomes

Brantley

2021

Med Care Res Rev

Self Cite

View full text Add to dashboard Cite

Fluctuating insurance coverage, or churning, is a recognized barrier to health care access. We assessed whether state policies that allow children to remain covered in Medicaid for a 12-month period, regardless of fluctuations in income, are associated with health and health care outcomes, after controlling for individual factors and other Medicaid policies. This cross-sectional study uses a large, nationally representative database of children ages 0 to 17. Continuous eligibility was associated with improved rates of insurance, reductions in gaps in insurance and gaps due to application problems, and lower probability of being in fair or poor health. For children with special health care needs, it was associated with increases in use of medical care and preventive and specialty care access. However, continuous eligibility was not associated with health care utilization outcomes for the full sample. Continuous eligibility may be an effective strategy to reduce gaps in coverage for children and reduce paperwork burden on Medicaid agencies.

show abstract

Health Reform, Medicaid Expansions, and Women's Cancer Screening

Cited by 12 publications

References 21 publications

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

The financial burden and distress of patients with cancer: Understanding and stepping‐up action on the financial toxicity of cancer treatment

Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies

Continuous Eligibility for Medicaid Associated With Improved Child Health Outcomes

Contact Info

Product

Resources

About